KCl reversal of insulin inhibition and fade in pentagastrin-stimulated gastric secretion.
D000818:Animals; D004285:Dogs; D004947:Esophagus / Q000502:physiology; D005750:Gastric Juice / Q000032:analysis / Q000378:metabolism*; D005768:Gastrointestinal Hormones / Q000037:antagonists & inhibitors*; D006400:Hematocrit; D007003:Hypoglycemia / Q000139:chemically induced / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology*; D010418:Pentagastrin / Q000037:antagonists & inhibitors; D010435:Pepsinogens / Q000378:metabolism; D010455:Peptides / Q000037:antagonists & inhibitors*; D011188:Potassium / Q000032:analysis / Q000097:blood; D011189:Potassium Chloride / Q000494:pharmacology*; D012636:Secretory Rate / Q000187:drug effects; D012964:Sodium / Q000097:blood; D013270:Stomach / Q000502:physiology
D005768:Gastrointestinal Hormones; D007328:Insulin; D010435:Pepsinogens; D010455:Peptides; D011189:Potassium Chloride; D012964:Sodium; D010418:Pentagastrin; D011188:Potassium